All animal use conformed to the European Community guidelines and was approved by the local ethics committee (Comité d'éthique en expérimentation animale N° 121) and the Ministry of Higher Education and Research (Ref #02285.03).
1. Animals and Diets
2. Material
3. Surgery
4. Postoperative Care
This protocol is reproducible and mimics OAGB as practiced on humans. The safety of this protocol is supported with published data23,24 with a low mortality rate between 12% and 25%. Different surgeons in the research team with a similar mortality rate have practiced this protocol.
Nonetheless, learning rodent surgery is complex, and the use of magnifying glasses is mandatory. Indeed, the critical step of the construction of a microscopic anastomosis requires a learning period from around 15 to 20 operations to reach an optimal dexterity. A surgical defect can lead to an anastomotic leakage of a gastric obstruction, which is the main death cause in our experience. Another key to success is the postoperative nutrition; indeed, an early postoperative solid nutrition can be dangerous. This protocol also provides a precise postoperative nutrition protocol, which has been demonstrated to be safe. The concept of this surgery on humans and on rats is illustrated in Figure 1. A result of the operation after sacrifice is provided in Figure 2.
Results obtained on weight loss after operation on obese rats were quite similar to those observed in humans, with a body weight loss of about 20%, stable after the operation. The results are detailed in Figure 3. Better insulin sensitivity and glucose tolerance were observed as soon as 2 weeks after the surgery, as assayed by an oral glucose test (OGTT) and an insulin tolerance test (ITT). These results are detailed in Figure 4. HFD-induced obesity has been described to promote insulin resistance and glucose intolerance in Wistar rats25; comparable data have been gathered in our unit (unpublished). Wistar rats are not a model of type 2 diabetes.
Figure 1: Illustration of OAGB on humans and on this rat model. (A) Scheme of an OAGB in humans; the gastric pouch is long and tubular and the BPL measures between 150 and 200 cm. (B) Rat model of an OAGB. The ratio of the BPL and the AL/CL reproduce the one practiced for human surgery; the BPL measures 35 cm. Abbreviations: GP = gastric pouch; Ana = anastomosis; AL = alimentary limb; CL = common limb. Please click here to view a larger version of this figure.
Figure 2: Illustration of OAGB on rats after sacrifice. Abbreviations: GP = gastric pouch; Ana = anastomosis; AL = alimentary limb; CL = common limb; Oes = Esophagus; Duo = duodenum Please click here to view a larger version of this figure.
Figure 3: Postoperative weight evolution (median ± SD) after OAGB and sham surgery. The sham surgery consisted of a laparotomy and a pinch on the great gastric curve with non-traumatic forceps. Please click here to view a larger version of this figure.
Figure 4: Glucose metabolism after OAGB and sham surgery; post-operative OGTT and ITT. (A) Post-operative OGTT. OAGB and sham rats were made to fast before being subjected to an oral glucose tolerance test (OGTT: 1 g/kg of body weight). (B) Post-operative ITT: an injection of 1 U insulin/kg of body weight. Rats were made to fast 4 h before receiving the insulin injection. Blood was harvested in the tail vein at t = 0 and at 10, 20, 30, 60, and 120 min after the insulin or glucose administration. Glucose was measured using a blood glucose meter. Glycemia was expressed in mg/dL ± standard deviation. Abbreviations:OGTT = oral glucose tolerance test; ITT = insulin tolerance test; BW = body weight. * p < 0.05, ** p < 0.01, *** p < 0.001; after two-way ANOVA statistical test. The sham surgery consisted of a laparotomy with a nontraumatic pinch of the great gastric curve using non-traumatic forceps. All data are presented as mean ± SD. Please click here to view a larger version of this figure.
High-Fat Diet, 45 % fat | Genestil, Royaucourt, France | C 1090-45 | http://www.genestil.com/ |
Metzenbaum Scissors | World Precision instrument, Sarasota, US | 501739 | https://www.wpi-europe.com |
Dumont Tweezers | World Precision instrument, Sarasota, US | 14098 | https://www.wpi-europe.com |
Iris Forceps | World Precision instrument, Sarasota, US | 15915 | https://www.wpi-europe.com |
Iris Scissors 10cm | World Precision instrument, Sarasota, US | 14218 | https://www.wpi-europe.com |
Needle Holder | World Precision instrument, Sarasota, US | 14110 | https://www.wpi-europe.com |
Alm Self Retaining Retractor | World Precision instrument, Sarasota, US | 14240 | https://www.wpi-europe.com |
Baby Mixter Hemostatic Forceps, Right Angle | World Precision instrument, Sarasota, US | 501240 | https://www.wpi-europe.com |
Non woven sterile swabs | LCH Medical Products, Paris, France | SN40-0755 | www.lch-medical.com |
Galilean Binocular Loupe 2.5x | World Precision instrument, Sarasota, US | 504056 | https://www.wpi-europe.com |
Digestive thread: Isotactic polypropylene, monofil Prolene 7-0 | Ethicon, Issy les Moulineaux, France | EH7813E | www.ethicon.com |
Parietal thread : Coated Braided Polyester Ti-Cron 2-0 | Covidien, Mannsfield, MA, USA | 3003-52 | www.covidien.com |
Cutaneous thread : Polyglactin, VICRYL RAPIDE 4-0 | Ethicon, Issy les Moulineaux, France | VR3100 | www.ethicon.com |
ETS-Flex 35- mm staple gun | Ethicon, Issy les Moulineaux, France | ATS45 | www.ethicon.com |
Proximate Reloadable Staplers | Ethicon, Issy les Moulineaux, France | XR30V | www.ethicon.com |
TA-DST 30mm-3.5mm | Ethicon, Issy les Moulineaux, France | TX30B | www.ethicon.com |
Alcoholic 5% Betadine | MEDA Pharma, Merignac, France | 41085 | www.medapharma.fr |
LIDOCAINE AGUETTANT 20 mg/ml | LABORATOIRE AGUETTANT, Lyon, France | 3400940000000.0 | https://www.aguettant.fr |
Penicillin G 5MUI | Panpharma, Luitre, France | 3.40E+12 | https://www.panpharma.eu/fr |
Bionolyte G5 ; Sodium chloride 0.4%, glucose 5%, potassium chloride 0.2%) | Baxter, Maurepas, France | ||
Liquid diet | Genestil, Royaucourt, France | C-0200T | http://www.genestil.com/ |
Isoflurane 100% | Centravet, Plancoet, France | ISO007 | http://cooperative.centravet.net |
The goal of this protocol is to set up a preclinical model of bariatric surgery and, more specifically, OAGB in obese rats. Based on this preclinical model, longitudinal studies can be carried out to provide an improved understanding of the mechanisms underlying the outcomes seen after bariatric surgery in humans. For this purpose, rats are operated on through a laparotomy under general anesthesia with isoflurane. First, the surgeon creates a long and tubular gastric pouch: after greater curve and hiatal dissection, the nonglandular stomach is stapled and removed. Then, the remaining stomach is also stapled in order to create a gastric tube and exclude the antrum of the stomach. After that, the surgeon performs a single end-to-side gastrojejunostomy 35 cm from the duodenojejunal angle. This limb length has been chosen in order to reproduce the same ratio between the biliopancreatic limb (BPL) and common limb (CL) length as in human bariatric surgery. The operation ends by aponeurotic and cutaneous closure. The early postoperative management consists of subcutaneous hydration, an intramuscular prophylactic antibiotic injection, a parietal injection of xylocaine, the administration of painkillers, and a progressive reintroduction of diet.
The goal of this protocol is to set up a preclinical model of bariatric surgery and, more specifically, OAGB in obese rats. Based on this preclinical model, longitudinal studies can be carried out to provide an improved understanding of the mechanisms underlying the outcomes seen after bariatric surgery in humans. For this purpose, rats are operated on through a laparotomy under general anesthesia with isoflurane. First, the surgeon creates a long and tubular gastric pouch: after greater curve and hiatal dissection, the nonglandular stomach is stapled and removed. Then, the remaining stomach is also stapled in order to create a gastric tube and exclude the antrum of the stomach. After that, the surgeon performs a single end-to-side gastrojejunostomy 35 cm from the duodenojejunal angle. This limb length has been chosen in order to reproduce the same ratio between the biliopancreatic limb (BPL) and common limb (CL) length as in human bariatric surgery. The operation ends by aponeurotic and cutaneous closure. The early postoperative management consists of subcutaneous hydration, an intramuscular prophylactic antibiotic injection, a parietal injection of xylocaine, the administration of painkillers, and a progressive reintroduction of diet.
The goal of this protocol is to set up a preclinical model of bariatric surgery and, more specifically, OAGB in obese rats. Based on this preclinical model, longitudinal studies can be carried out to provide an improved understanding of the mechanisms underlying the outcomes seen after bariatric surgery in humans. For this purpose, rats are operated on through a laparotomy under general anesthesia with isoflurane. First, the surgeon creates a long and tubular gastric pouch: after greater curve and hiatal dissection, the nonglandular stomach is stapled and removed. Then, the remaining stomach is also stapled in order to create a gastric tube and exclude the antrum of the stomach. After that, the surgeon performs a single end-to-side gastrojejunostomy 35 cm from the duodenojejunal angle. This limb length has been chosen in order to reproduce the same ratio between the biliopancreatic limb (BPL) and common limb (CL) length as in human bariatric surgery. The operation ends by aponeurotic and cutaneous closure. The early postoperative management consists of subcutaneous hydration, an intramuscular prophylactic antibiotic injection, a parietal injection of xylocaine, the administration of painkillers, and a progressive reintroduction of diet.